How to make poison cough syrups

Published Date: 14 Mar 2023

According to market research firm Euromonitor, the global children's cough, cold and allergy products market in 2022 is worth $2.5 billion.

Read Full News

Latest News

One Shot or Two? What to Know About HPV Vaccination Recommendations

— Guidance is evolving

What's Behind Boy's Bullous Skin Lesions After Flu Symptoms?

Mycoplasma pneumonia identified as the culprit in this case of RIME

Meta's $17.1 Billion Settlement: A Chance for a Social Media Natural Experiment

Whether it advances the science depends on who can study the results

CDC, Epidemiologists Work on Definition for Measles Deaths

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Todays Updates

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

Distinguishing Lambert-Eaton Myasthenic Syndrome From Ocular Myasthenia Gravis in the Eye Clinic Marco Meglio

Kiril Kiprovski, MD, clinical professor of neurology and director of the Division of Neuromuscular Medicine at NYU Langone, reviews the clinical clues, bedside tests, and referral considerations that help eye care clinicians identify Lambert-Eaton myasthenic syndrome in patients with fluctuating ptosis or diplopia.

PREVAiLS Phase 3 Trial Evaluates Pridopidine in Early, Rapidly Progressive ALS Louie Pasculli

The 500-participant study will assess whether pridopidine, an investigational sigma-1 receptor agonist, can slow functional decline and improve survival in patients with early, rapidly progressing amyotrophic lateral sclerosis.

Latest News

— Guidance is evolving

Mycoplasma pneumonia identified as the culprit in this case of RIME

Whether it advances the science depends on who can study the results

Standard workgroup process began over the summer

Navigating the Evolving Treatment Landscape in SMA: An Interactive Clinical Decision-Making Simulation

Navigating the Spectrum of SMA: From Genetic Insights to Timely Diagnosis

News All Time

Vax Beliefs of HHS Deputy Secretary Nominee Probed at Hearing

Chris Klomp praised the MMR vaccine, but Sen. Wyden said Klomp's answers "created confusion"

Inquiry Slams Hospital for Failure to Protect Babies After Nurse's Murder Conviction

Concerns were kept quiet as babies fell ill at hospital where Lucy Letby worked

Twins Conjoined at Head Separated; Brain-Eating Amoeba Source; Mercury-Laden Lotion

Health news and commentary gathered by MedPage Today staff

Where Does Medicine's Responsibility for Human Trafficking End?

Public health is political, but it doesn't have to be partisan, says Nicholas Peoples, MD

RFK Jr. Picks New USPSTF Members

Under Kennedy's scrutiny, the preventive services panel hasn't met in more than a year

Mysterious Stomach Rash Had Unusual Source

It stemmed from prolonged contact with a certain device

RFK Jr. Bolsters Vaccine Skepticism at Children's Health Defense Conference

"We have started to ask the questions that you ... have been asking for years," he said

Doc Running for Congress Calls RFK Jr. 'Dangerous and Incompetent'

Community health and vaccination rates are big issues for California pediatrician

Stuttering: New Consensus Statement Highlights Neurobiology

New consensus guideline frames stuttering as a neurobiological condition, emphasizing that physicians play a crucial role in diagnosis and ongoing management.

NHS Alliance Warns ADHD, Autism Costs Spiralling

NHS leaders say soaring ADHD and autism assessment costs are forcing service cuts and disrupting long-term planning.

Meta Settlement Falls Short on Teen Mental Health Protections, Whistleblower Says

(This August 27 story has been republished to add an image, with no changes to text.)

A Camp for Children With Brain Injuries Zips Ahead

A Pennsylvania camp gives children and young adults with brain injuries a place to connect, but federal funding for traumatic brain injury programs remains uncertain.

Gabapentin Not Linked to Better Outcomes for Kids’ Migraine

For children hospitalized with migraine, gabapentin use wasn’t associated with less pain or fewer readmissions than no use in an observational study.

This 'Natural' Remedy Was Likely Culprit in Baby's Lead Poisoning

Clinicians should ask parents about all meds, traditional and complementary, expert advises

Are Suicide Attempts Contagious in Young People?

— "We know that suicidal behavior does not occur in a social vacuum," researcher says

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Dravet Syndrome: Optimizing Early Diagnosis and Treatment Strategies

Recommended News For You

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

In cancer survivors, loneliness is associated with a higher risk of death.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

Independent Risk Factors for "Deaths of Despair" Found.

Higher levels of HIF2α found to slow down aggressive childhood cancer

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

Recommended Articles For You

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer 

Prevention Through Preservation of Hematopoietic Reserve During Chronic Physiological Stress 

Pediatric Hematopoietic Niche Remodeling With Age 

Practical Developments in Hematology in the Digital Era 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

2.

Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma

3.

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

4.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

5.

A Possible Novel CAR-T Treatment for High-Risk R/R Follicular Lymphoma May Be Liso-Cel.

1.

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy

2.

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers

3.

Case Study: Genomic Medicine in Precision Oncology

4.

Cancer Enhancer Rewiring and Tumor Cell Identity

5.

Risk Assessment of Iron Overload in Repeated Transfusion

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Chemotherapy: What to Expect

3.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

5.

Updates on Standard V/S High Risk Myeloma Treatment- The Next Part

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot